Medicare Enrolled
Dr. Pareshkumar Patel, MD
Medical Oncology · Tallahassee, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Pareshkumar Patel is a medical oncology in Tallahassee, FL, with 19 years in practice. Based on federal Medicare data, Dr. Patel performed 34,765 Medicare services across 1,518 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $33,728 from 86 pharmaceutical and/or device companies across 592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 38% volume in FL$ $33,728 industry payments
Medicare Practice Summary
Medicare Utilization ↗34,765
Medicare services
Top 38% in FL for medical oncology
1,518
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,830 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 11,730 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 10,790 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,720 | $18 | $51 |
| Dexamethasone injection (steroid) | 2,027 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,146 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,030 | $1 | $28 |
| Blood draw (venipuncture) | 992 | $8 | $9 |
| Anti-nausea injection (ondansetron/Zofran) | 580 | $0 | $9 |
| Office visit, established patient (30-39 min) | 498 | $96 | $339 |
| Administration of chemotherapy into vein, 1 hour or less | 330 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 255 | $22 | $84 |
| Injection of additional new drug or substance into vein | 252 | $12 | $61 |
| Drug injection, under skin or into muscle | 228 | $10 | $69 |
| Office visit, established patient (20-29 min) | 207 | $62 | $239 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 183 | $45 | $189 |
| Injection, diphenhydramine hcl, up to 50 mg | 111 | $1 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 81 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 73 | $49 | $178 |
| Administration of additional new drug or substance into vein using push technique | 65 | $42 | $170 |
| Automated urinalysis | 61 | $2 | $8 |
| Injection of drug or substance into vein | 59 | $27 | $156 |
| Administration of chemotherapy into vein, each additional hour | 52 | $21 | $79 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 52 | $3 | $11 |
| Infusion, normal saline solution , 1000 cc | 48 | $2 | $7 |
| Infusion into a vein for hydration, each additional hour | 44 | $10 | $42 |
| New patient office visit, complex (60-74 min) | 24 | $155 | $585 |
| Initial hospital admission, high complexity | 24 | $125 | $556 |
| New patient office visit (45-59 min) | 23 | $112 | $453 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $15 | $59 |
| Office visit, established patient, complex (40-54 min) | 23 | $140 | $474 |
| Red blood count, automated test | 17 | $4 | $10 |
| New patient office visit (30-44 min) | 17 | $82 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
35.3% high complexity
55.6% medium
9.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,728
Total received (2018-2024)
Avg $4,818/year across 7 years
Top 16% in FL for medical oncology
86
Companies
592
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,058 (41.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,529 (31.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,141 (27.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$11,638
2023$2,024
2022$1,892
2021$2,089
2020$2,157
2019$4,920
2018$9,008
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$9,581
Celgene Corporation
$9,203
Verastem, Inc.
$3,073
Rigel Pharmaceuticals, Inc.
$1,032
Seattle Genetics, Inc.
$835
Novartis Pharmaceuticals Corporation
$777
AstraZeneca Pharmaceuticals LP
$765
Astellas Pharma US Inc
$515
E.R. Squibb & Sons, L.L.C.
$468
Genentech USA, Inc.
$431
Merck Sharp & Dohme LLC
$427
JAZZ PHARMACEUTICALS INC.
$416
Regeneron Healthcare Solutions, Inc.
$412
Octapharma USA, Inc.
$396
Janssen Biotech, Inc.
$356
Ipsen Biopharmaceuticals, Inc
$317
Amgen Inc.
$315
Daiichi Sankyo Inc.
$313
GlaxoSmithKline, LLC.
$271
Merck Sharp & Dohme Corporation
$266
Eisai Inc.
$252
Exelixis Inc.
$197
Incyte Corporation
$163
GENZYME CORPORATION
$156
Seagen Inc.
$147
ABBVIE INC.
$143
Alexion Pharmaceuticals, Inc.
$130
Johnson & Johnson Health Care Systems Inc.
$116
ARRAY BIOPHARMA INC
$97
Gilead Sciences, Inc.
$91
Pharmacyclics LLC, An AbbVie Company
$90
Bayer HealthCare Pharmaceuticals Inc.
$88
Pharmacosmos Therapeutics Inc.
$88
Stemline Therapeutics Inc.
$85
Takeda Pharmaceuticals U.S.A., Inc.
$83
AbbVie Inc.
$77
Janssen Pharmaceuticals, Inc
$58
TAIHO ONCOLOGY, INC.
$57
Coherus Biosciences Inc.
$56
PUMA BIOTECHNOLOGY, INC.
$56
AMAG Pharmaceuticals, Inc.
$54
Kite Pharma, Inc.
$53
Blueprint Medicines Corporation
$53
Lexicon Pharmaceuticals, Inc.
$52
SOBI, INC
$50
Karyopharm Therapeutics Inc.
$48
Heron Therapeutics, Inc.
$47
CSL Behring
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
EISAI INC.
$44
Chiesi USA, Inc.
$40
Pharmacyclics LLC, an AbbVie Company
$39
SUN PHARMACEUTICAL INDUSTRIES INC.
$39
Sysmex Inostics Inc
$36
G1 Therapeutics, Inc.
$35
PharmaEssentia USA Corporation
$33
Jazz Pharmaceuticals Inc.
$32
Aveo Pharmaceuticals, Inc.
$32
EMD Serono, Inc.
$31
AbbVie, Inc.
$31
Dendreon Pharmaceuticals LLC
$30
SERVIER PHARMACEUTICALS LLC
$30
Lilly USA, LLC
$30
GE HealthCare
$28
Secura Bio, Inc.
$28
Acrotech Biopharma LLC
$25
Grifols USA, LLC
$25
Bayer Healthcare Pharmaceuticals Inc.
$21
MorphoSys, US Inc.
$21
ImmunoGen, Inc.
$20
CTI BioPharma Corp.
$18
Emmaus Medical, Inc.
$18
Allergan, Inc.
$18
Alnylam Pharmaceuticals Inc.
$16
Deciphera Pharmaceuticals Inc.
$16
Epizyme, Inc.,
$16
Immunocore Limited
$15
Global Blood Therapeutics, Inc.
$14
Clovis Oncology, Inc.
$14
Novo Nordisk Inc
$13
Mirati Therapeutics, Inc.
$13
Nestle HealthCare Nutrition Inc.
$13
Janssen Scientific Affairs, LLC
$13
TG Therapeutics, Inc.
$12
Kyowa Kirin, Inc.
$11
Sirtex Medical Inc
$7
Top 3 companies account for 64.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AYVAKIT · Afstyla · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · Cabometyx · Cinvanti · Copiktra · DALVANCE · DARZALEX · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · ENTRESTO · ERLEADA · Elahere · Endari · Enhertu · Entyvio · Erleada · FARESTON · FERAHEME · FOTIVDA · Fabhalta · Farydak · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · Idelvion · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KENGREAL · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Novoeight · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Phesgo · Polivy · Pomalyst · Prolastin-C Liquid · QINLOCK · REBLOZYL · REMICADE · RYDAPT · Revlimid · Rubraca · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tibsovo · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VRAYLAR · Venclexta · Vitrakvi · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZENPEP · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (42%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.
Equivalent to $97 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
5
Per 100K population
1.7
County median income
$65,074
Nearest hospital
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 16%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Patel performed 11,730 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $33,728 from 86 companies across 592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other medical oncologys in Tallahassee?
Dr. Patel's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Tallahassee
Browse medical oncologys in Tallahassee ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Verastem, Inc. Payments to Doctors
See all physicians who received payments from Verastem, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology